Current Science

Open Access Open Access  Restricted Access Subscription Access

Analysis of in Vitro and in silico Anti-Hyperglycaemic Action of Bioflavonoids Isolated from Different Citrus Peels


Affiliations
1 Department of Pharmaceutical Technology, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli 620 024, India
 

In this study, flavonoid-rich chloroform fraction (FRCF) of nine different citrus species was isolated by solvent fractionation technique and its effect on α- glucosidase, α-amylase, glucose uptake by yeast cells and glycosylation of haemoglobin was studied. FRCF of Citrus maxima was found to show higher activity in the in vitro assays and thus it was characterized by Electrospray Ionization Mass Spectrometry (ESI-MS) analysis. This led to the identification of icariin, hesperidin and diosmetin-6,8-di-C-glucoside. Their binding efficacy with targeted proteins such as glucokinase (GK), glycogen synthase kinases 3β (GSK 3β) and peroxisome proliferator-activated receptor-γ (PPAR-γ ) was studied by in silico analysis using Schrödinger Maestro software. Icariin exhibited maximum docking energy with GSK 3β, relatively less for GK and null for PPAR-γ. Hesperidin and diosmetin-6, 8-di-C-glucoside showed good binding affinity with PPAR-γ compared to GSK 3β.

Keywords

Anti-Hyperglycaemic Activity, Bioflavonoids, Citrus maxima, Yeast Cells.
User
Notifications
Font Size

  • NCD Risk Factor Collaboration (NCD-RisC), Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet, 2016, 387, 1513– 1530.

  • Raza, H., Prabu, S. K., Robin, M. and Avadhani, N. G., Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats. Diabetes, 2004, 53(1), 185–194.

  • Kamata, K., Mitsuya, M., Nishimura, T., Eiki, J. and Nagata, Y., Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase. Structure, 2004, 12, 429–438.

  • Takano, H. and Komuro, I., Peroxisome proliferator-activated receptorγ and cardiovascular diseases. Circ. J., 2009, 73, 214–220.

  • Luna, B. and Feinglos, M. N., Oral agents in the management of type 2 diabetes mellitus. Am. Fam Physician, 2001, 63, 1747– 1756.

  • Nolte, M. S. and Karam, J. H., Pancreatic hormones and antidiabetic drugs. In Basic and Clinical Pharmacology (ed. Katzung B. G.), Lange Medical Books, McGraw-Hill, San Francisco, USA, 2001, 8th edn, pp. 711–734.

  • Abirami, A., Nagarani, G. and Siddhuraju, P., In vitro antioxidant, anti-diabetic, cholinesterase and tyrosinase inhibitory potential of fresh juice from Citrus hystrix and C. maxima fruits. Food Sci. Hum. Wellness, 2014, 3, 16–25.

  • Valiathan, M. S., Healing plants. Curr. Sci., 1998, 75, 1122– 1126.

  • Ahmed, A. B. A., Rao, A. S. and Rao, M. V., In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulate β-cells regeneration and anti-diabetic activity in Wistar rats. Phytomedicine, 2010, 17, 1033–1039.

  • Shirzad, H., Taji, F. and Rafieian-kopaei, M., Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. J. Med. Food, 2011, 14, 969– 974.

  • Sakai, I., Izumi, S. I., Murano, T., Okuwaki, S., Makino, T. and Suzuki, T., Presence of aldose reductase inhibitors in tea leaves. Jpn. J. Pharmacol., 2001, 85, 322–326.

  • Kumar, P. R. Z. A. and Bhaskar, A., Evaluation of antihyperglycaemic and antihyperlipidemic activity of Citrus sinensis peel extract on streptozotocin-induced diabetic rats. Int. J. Diab. Dev. Ctries., 2015, 35, 448.

  • Kundu Sen, S. et al., Antihyperglycaemic effect and antioxidant property of Citrus maxima leaf in streptozotocin induced diabetic rats. Diabetol. Croatia, 2011, 40, 113–120.

  • Kundusen, S. et al., Evaluation of antihyperglycaemic activity of Citrus limetta fruit peel in streptozotocin-induced diabetic rats. ISRN Endocrinol., 2011, 1, 1–6.

  • Kamal, M., Youssef, E., Youssef, M. K. E. and Mousa, R. M. A., Evaluation of antihyperglycaemic activity of citrus peels powders fortified biscuits in albino induced diabetic rats. Food Public Health, 2013, 3, 161–167.

  • Alam, M. A., Subhan, N., Rahman, M. M., Uddin, S. J., Reza, H. M. and Sarker, S. D., Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv. Nutr., 2014, 5, 404–417.

  • Vijaylakshmi, P. and Radha, R., An overview: Citrus maxima. J. Phytopharmacol., 2015, 4, 263–267.

  • Geldenhuys, W. J., Gaasch, K. E., Watson, M., Allen, D. D. and Schyf, C. V., Optimizing the use of open-source software applications in drug discovery. Drug Discov. Today, 2006, 11, 127– 132.

  • Harborne, J. B., Phytochemical methods. In A Guide to Modern Techniques of Plant Analysis, Chapman and Hall Int. Ed., NY, USA, 1998, 3rd edn, pp. 49–188.

  • Chang, C., Yang, M., Wen, H. and Chern, J., Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food Drug Anal., 2002, 10, 178–182.

  • Miller, G. L., Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal. Chem., 1959, 31, 426–428.

  • Watanabe, J., Kawabata, J., Kurihara, H. and Niki, R., Isolation and identification of α-glucosidase inhibitors from tochu-cha (Eucommia ulmoides). Biosci. Biotechnol. Biochem., 1997, 61, 177–178.

  • Adisa, R. A., Oke, J., Olomu, S. A. and Olorunsogo, O., Inhibition of human haemoglobin glycosylation by flavonoid containing leaf extract of Cnestis ferruginea. J. Cameroon Acad. Sci., 2004, 4, 351–359.

  • Cirillo, V. P., Mechanism of glucose transport across the yeast cell membrane. J. Bacteriol., 1962, 84, 485–491.

  • Suite, S., Maestro User Manual: Maestro Version 9.2, Schrodinger, LLC, New York, USA, 2011.

  • Ghasemi, K., Ghasemi, Y. and Ebrahimzadeh, M. A., Antioxidant activity, phenol and flavonoid contents of 13 citrus species peels and tissues. Pak. J. Pharm. Sci., 2009, 22, 277–281.

  • Choi, S. Y. et al., Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Biol. Pharm. Bull., 2007, 30(4), 772–778.

  • Bocco, A., Cuvelier, M., Richard, H. and Berset, C., Antioxidant activity and phenolic composition of citrus peel and seed extracts. J. Agric. Food Chem., 1998, 46(6), 2123–2129.

  • Lebovitz, H. E., Alpha-glucosidase inhibitors. Endocrinol. Metab. Clin. North Am., 1997, 26, 539–551.

  • Liu, G., Chemical compositions, α-glucosidase and α-amylase inhibitory activities of crude polysaccharides from the endodermis of shaddock (Citrus maxima). Arch. Biol. Sci., 2012, 64(1), 71–76.

  • Oboh, G. and Ademosun, A. O., Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management. Diabetes Metab. Syndr: Clin., 2011, 5, 148–152.

  • Ernawita, Agung Wahyuono, R., Hesse, R., Hipler, U., Elsner, P. and Böhm, V., In vitro lipophilic antioxidant capacity, antidiabetic and antibacterial activity of citrus fruits extracts from Aceh, Indonesia. Antioxidants, 2017, 6, 11.

  • Kawabata, H., Takeda, R., Nakanishi, M., Shintani, S., Iida, A. and Sawabe, A., Evaluation of the alpha-glucosidase inhibitory activity of flavonoids in the peelings of Citrus dekopon ((Citrus unshiu × C. Sinensis) × C. Reticulata). J. Anal. Bioanal. Tech., 2013, 4, 5.

  • Wei, D. Q. and Zhong, W. Z., Binding mechanism of corona virus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Commun., 2003, 308, 148– 151.

  • Wang, J. F., Wei, D. Q., Li, L. and Zheng, S. Y., 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. Biochem. Biophys. Res. Commun., 2007, 355, 513–519.

  • Rathore, P. K., Arathy, V., Vijaylaxmi, S., Kumar, A. P. and Roy, S., In silico analysis of gymnemagenin from Gymnema sylvestre (Retz.) R.Br. with targets related to diabetes. J. Theor. Biol., 2016, 391, 95–101.

  • Shen, W. and Lu, Y., Molecular docking of citrus flavonoids with some targets related to diabetes. Bangladesh J. Pharmacol., 2013, 8, 156–170.

  • Salam, N. K., Huang, T. H. W., Kota, B. P., Kim, M. S., Li, Y. and Hibbs, D. E., Novel PPAR-gamma agonists identified from a natural product library: a virtual screening induced-fit docking and biological assay study. Chem. Biol. Drug Design., 2008, 71, 57– 70.

  • Bao, H. and Chen, L., Icariin reduces mitochondrial oxidative stress injury in diabetic rat hearts. Chin. Mater. Med., 2011, 36(11), 1503–1507.

  • Akiyama, S., Katsumata, S., Suzuki, K., Ishimi, Y., Wu, J. and Uehara, M., Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal Type 1 diabetic rats. J. Clin. Biochem. Nutr., 2010, 46(1), 87–92.

  • Ye, L., Chen, J. and Liu, S., Pharmacokinetics of icariin in rats. J. Chin Pharm., 1999, 34, 33–36.

  • Li, Y. et al., In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts. J. Agric. Food Chem., 2008, 56(14), 5550–5557.

  • Tang, L. et al., Use of glucuronidation fingerprinting to describe and predict mono- and dihydroxyflavone metabolism by recombinant UGT isoforms and human intestinal and liver microsomes. Mol. Pharm., 2010, 7, 664–679.


Abstract Views: 342

PDF Views: 99




  • Analysis of in Vitro and in silico Anti-Hyperglycaemic Action of Bioflavonoids Isolated from Different Citrus Peels

Abstract Views: 342  |  PDF Views: 99

Authors

E. Sanmuga Priya
Department of Pharmaceutical Technology, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli 620 024, India
P. Senthamil Selvan
Department of Pharmaceutical Technology, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli 620 024, India
A. Syed Arshad
Department of Pharmaceutical Technology, University College of Engineering, BIT Campus, Anna University, Tiruchirappalli 620 024, India

Abstract


In this study, flavonoid-rich chloroform fraction (FRCF) of nine different citrus species was isolated by solvent fractionation technique and its effect on α- glucosidase, α-amylase, glucose uptake by yeast cells and glycosylation of haemoglobin was studied. FRCF of Citrus maxima was found to show higher activity in the in vitro assays and thus it was characterized by Electrospray Ionization Mass Spectrometry (ESI-MS) analysis. This led to the identification of icariin, hesperidin and diosmetin-6,8-di-C-glucoside. Their binding efficacy with targeted proteins such as glucokinase (GK), glycogen synthase kinases 3β (GSK 3β) and peroxisome proliferator-activated receptor-γ (PPAR-γ ) was studied by in silico analysis using Schrödinger Maestro software. Icariin exhibited maximum docking energy with GSK 3β, relatively less for GK and null for PPAR-γ. Hesperidin and diosmetin-6, 8-di-C-glucoside showed good binding affinity with PPAR-γ compared to GSK 3β.

Keywords


Anti-Hyperglycaemic Activity, Bioflavonoids, Citrus maxima, Yeast Cells.

References





DOI: https://doi.org/10.18520/cs%2Fv115%2Fi10%2F1928-1937